FR2709062A1 - Plutonium-based composition for the homoeopathic prevention and treatment of HIV (human immunodeficiency virus) infection - Google Patents

Plutonium-based composition for the homoeopathic prevention and treatment of HIV (human immunodeficiency virus) infection

Info

Publication number
FR2709062A1
FR2709062A1 FR9310192A FR9310192A FR2709062A1 FR 2709062 A1 FR2709062 A1 FR 2709062A1 FR 9310192 A FR9310192 A FR 9310192A FR 9310192 A FR9310192 A FR 9310192A FR 2709062 A1 FR2709062 A1 FR 2709062A1
Authority
FR
France
Prior art keywords
plutonium
homoeopathic
hiv
treatment
immunodeficiency virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR9310192A
Other languages
French (fr)
Inventor
Lustig Didier Yves Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9310192A priority Critical patent/FR2709062A1/en
Priority to FR9312455A priority patent/FR2709063B1/en
Priority claimed from PCT/FR1994/001179 external-priority patent/WO1996011011A1/en
Publication of FR2709062A1 publication Critical patent/FR2709062A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo

Abstract

The invention relates, as a homoeopathic remedy, to a plutonium-based composition for the treatment of acquired immune deficiency syndrome (AIDS) and seropositivity for the human immunodeficiency virus (HIV) in man. The composition of the invention utilises any chemical and isotopic form of plutonium, diluted and dynamised according to the traditional methods employed in homoeopathy, especially the so-called Hahnemannian and Korsakovian methods, and preferably but not exclusively presented in the form of lactose granules or globules impregnated with the active principle of the aforementioned composition.
FR9310192A 1993-08-18 1993-08-18 Plutonium-based composition for the homoeopathic prevention and treatment of HIV (human immunodeficiency virus) infection Pending FR2709062A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9310192A FR2709062A1 (en) 1993-08-18 1993-08-18 Plutonium-based composition for the homoeopathic prevention and treatment of HIV (human immunodeficiency virus) infection
FR9312455A FR2709063B1 (en) 1993-08-18 1993-10-12 Composition based on one or more transuranic elements - and in particular plutonium - for the prevention and homeopathic treatment of infection with V.I.H ..

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9310192A FR2709062A1 (en) 1993-08-18 1993-08-18 Plutonium-based composition for the homoeopathic prevention and treatment of HIV (human immunodeficiency virus) infection
PCT/FR1994/001179 WO1996011011A1 (en) 1993-10-12 1994-10-11 Composition containing transuranic elements for use in the homeopathic treatment of aids

Publications (1)

Publication Number Publication Date
FR2709062A1 true FR2709062A1 (en) 1995-02-24

Family

ID=34809864

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9310192A Pending FR2709062A1 (en) 1993-08-18 1993-08-18 Plutonium-based composition for the homoeopathic prevention and treatment of HIV (human immunodeficiency virus) infection
FR9312455A Expired - Fee Related FR2709063B1 (en) 1993-08-18 1993-10-12 Composition based on one or more transuranic elements - and in particular plutonium - for the prevention and homeopathic treatment of infection with V.I.H ..

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR9312455A Expired - Fee Related FR2709063B1 (en) 1993-08-18 1993-10-12 Composition based on one or more transuranic elements - and in particular plutonium - for the prevention and homeopathic treatment of infection with V.I.H ..

Country Status (1)

Country Link
FR (2) FR2709062A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011011A1 (en) * 1993-10-12 1996-04-18 Didier Lustig Composition containing transuranic elements for use in the homeopathic treatment of aids

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011011A1 (en) * 1993-10-12 1996-04-18 Didier Lustig Composition containing transuranic elements for use in the homeopathic treatment of aids

Also Published As

Publication number Publication date
FR2709063B1 (en) 1996-07-12
FR2709063A1 (en) 1995-02-24

Similar Documents

Publication Publication Date Title
AUPO784197A0 (en) Treatment of nasopharyngeal carcinoma
DE69838986D1 (en) POLYPEPTIDES, THEIR PREPARATION AND USE
NZ335612A (en) A composition containing cytotoxic specificT-cell epitopes being either Rev and/or Tat proteins from HIV virus for prevention and treatment of human immunodeficiency virus (HIV) infection
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
PT726758E (en) PEPTIDES TO INDUCE RESPONSES OF CYTOTOXIC T-LYMPHOCYTES TO HEPATITIS B VIRUS
CA2218561A1 (en) Compounds and methods of use to treat infectious diseases
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0616535A4 (en) Method of treating viral infections.
GB8917256D0 (en) Biological preparation and its use
ES2113910T3 (en) PROCEDURE FOR THE PREPARATION OF A TROMBINE CONCENTRATE INSURED AGAINST VIRUSES.
FR2709062A1 (en) Plutonium-based composition for the homoeopathic prevention and treatment of HIV (human immunodeficiency virus) infection
WO2002020571A3 (en) Attenuated hiv strains and use thereof
WO1990013281A3 (en) Method of suppressing hiv infection
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
EP0325768A3 (en) Non-reverting rna viruses
ES2066753T3 (en) USE OF A PREPARATION, CONTAINING IMMUNOGLOBULIN, FOR THE PROPHYLAXIS AND THERAPY OF AIDS, IN PEOPLE.
ES2062990T3 (en) VACCINES, WHICH CONTAIN PROTEIN F FROM AIDS VIRUSES.
ES2162862T3 (en) USE OF TIMOSINE TO TREAT HEPATITIS C IN PATIENTS WHO DO NOT RESPOND TO THE INTERFER TREATMENT.
ZA945416B (en) Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans.
GR3029523T3 (en) Peptides that block human immunodeficiency virus infections and methods of use thereof
ZA945418B (en) Method of inhibiting the replication of human immunodeficiency viruses (HIV) in HIV seropositive humans.
MX164795B (en) INACTIVATION THROUGH PHENOLS OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV), IN PROTEIN CONTENT SOLUTIONS
MD1051C2 (en) Antiherpetic remedy